Notice of Proposed Sale · 144
Merck & Co., Inc.
MRKNYSEEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- MERCK & CO., INC.
- Issuer CIK
- 0000310158
- SEC file number
- 001-06571
- Phone
- (732) 594-4000
- Person for whose account securities are to be sold
- JENNIFER L ZACHARY
- Relationships to issuer
- Officer
- Street
- 126 East Lincoln Avenue
- City
- Rahway
- State / country code
- NJ
- Postal code
- 07065
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common | 80,315 | 10,718,494.55 | 2,467,171,638 | 08/12/2026 | NYSE | Morgan Stanley Smith Barney LLC Executive Financial Services |
Broker / market maker — proposed row 1, entry 1
- Name
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Street
- 1 New York Plaza
- Street (continued)
- 8th Floor
- City
- New York
- State / country code
- NY
- Postal code
- 10004
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common | 08/12/2026 | Exercise of Options Under a Registered Plan | Issuer | 41,494 | N | 08/12/2026 | Cash |
| Common | 08/12/2026 | Exercise of Options Under a Registered Plan | Issuer | 13,433 | N | 08/12/2026 | Cash |
| Common | 04/11/2023 | Restricted Stock Vesting Under a Registered Plan | Issuer | 348 | N | 04/11/2023 | Not Applicable |
| Common | 07/11/2023 | Restricted Stock Vesting Under a Registered Plan | Issuer | 235 | N | 07/11/2023 | Not Applicable |
| Common | 10/09/2023 | Restricted Stock Vesting Under a Registered Plan | Issuer | 248 | N | 10/09/2023 | Not Applicable |
| Common | 01/09/2024 | Restricted Stock Vesting Under a Registered Plan | Issuer | 229 | N | 01/09/2024 | Not Applicable |
| Common | 01/22/2024 | Restricted Stock Vesting Under a Registered Plan | Issuer | 23,298 | N | 01/22/2024 | Not Applicable |
| Common | 04/08/2024 | Restricted Stock Vesting Under a Registered Plan | Issuer | 176 | N | 04/08/2024 | Not Applicable |
| Common | 07/09/2024 | Restricted Stock Vesting Under a Registered Plan | Issuer | 179 | N | 07/09/2024 | Not Applicable |
| Common | 10/08/2024 | Restricted Stock Vesting Under a Registered Plan | Issuer | 209 | N | 10/08/2024 | Not Applicable |
| Common | 07/08/2026 | Restricted Stock Vesting Under a Registered Plan | Issuer | 466 | N | 07/08/2026 | Not Applicable |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Notice signature
- Notice date
- 08/12/2026
- Signed
- /s/ Jennifer Zachary
Company context
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world - and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.